Insider Transactions in Q1 2026 at Nurix Therapeutics, Inc. (NRIX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2026
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,760
-6.88%
|
$67,680
$18.42 P/Share
|
|
Jan 20
2026
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+6.44%
|
$3,760
$1.86 P/Share
|